BrainStorm Cell Therapeutics Inc (BCLI)

[sokol]

Yes, it could take a couple of years or more. However, I am thinking that, if the safety issue is not a problem, access may be gained sooner through compassionate use or some accelerated approval due to the nature of the diseases involved. It may be that Brainstorm may need to establish that NurOwn is safe for each of these diseases. In other words, is there anything about these other diseases that may pose a safety issue if those patients are administered NurOwn? There is also speculation that there may be faster approvals of drugs for serious diseases as a result of the pandemic approvals of vaccines and drugs to treat the C-virus. The pandemic approvals may be considered a precedent for speeding up approval of these drugs.